Literature DB >> 2561180

Non-enzymic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product, C5b-like C5.

W Vogt1, B Damerau, I von Zabern, R Nolte, D Brunahl.   

Abstract

Purified human C5 was converted non-enzymically to an activated form as defined by its ability to participate in reactive lysis. This conversion occurred following exposure to systems that generate oxygen radicals, namely addition of H2O2 in the presence of ascorbic acid and iron or the addition of xanthine oxidase, acetaldehyde and iron. The conversion of C5 to a functionally active species was iron-dependent and inhibited by hydroxyl radical scavengers such as DMSO. The findings suggest that OH. is the active oxygen species that converts C5. The conversion product of C5, termed C5(H2O2), is C5b-like due to its ability to bind C6 and cause reactive lysis. C5(H2O2) is much more stable than C5b obtained by complement convertases. Although C5(H2O2) has lost the binding site of native C5 for C3b it can be cleaved by complement-derived convertases; the cleavage is, however, less efficient than in the case of native C5. The resulting cleavage product, which is C5a-like, is chemotactic although C5(H2O2) is not chemotactic. C5(H2O2) serves as a better substrate for plasma kallikrein than native C5, resulting in the generation of a C5a-like chemotactic product. These data indicate that oxygen radicals can bring about a conformational change in C5, causing it to behave as a functionally activated molecule of the complement system. This may have implications for the role of complement and its activation in the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2561180     DOI: 10.1016/0161-5890(89)90057-6

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model.

Authors:  B H M Heijnen; I H Straatsburg; N D Padilla; G J Van Mierlo; C E Hack; T M Van Gulik
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

2.  In vivo recruitment of neutrophils: consistent requirements for L-arginine and variable requirements for complement and adhesion molecules.

Authors:  M S Mulligan; A B Lentsch; P A Ward
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

3.  Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?

Authors:  Wesley E Stites; Jeffrey W Froude
Journal:  Med Hypotheses       Date:  2006-10-24       Impact factor: 1.538

4.  Normal pregnancy is characterized by systemic activation of the complement system.

Authors:  Karina Richani; Eleazar Soto; Roberto Romero; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Samuel Edwin; Yeon Mee Kim; Joon-Seok Hong; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2005-04

5.  Cleavage of human complement component C5 by cysteine proteinases from Porphyromonas (Bacteroides) gingivalis. Prior oxidation of C5 augments proteinase digestion of C5.

Authors:  R G Discipio; P J Daffern; M Kawahara; R Pike; J Travis; T E Hugli; J Potempa
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

6.  Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis.

Authors:  M S Mulligan; S Moncada; P A Ward
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.